A
SRA / Scientist, Lipid Nanoparticle (LNP) Discovery - Contractor
Addition Therapeutics
حضوريبيانات
من الإعلان الأصلي
South San Francisco Company Addition Therapeutics is at the forefront of biotechnology innovation and is building the next generation of gene therapy using our proprietary PRINT™ (Programmable RNA-guided Integration Technology) platform. PRINT™ redefines genetic medicine by enabling development of RNA-only therapeutics capable of inserting any genetic element into specific safe harbor sites within the genome. Operating from state-of-the-art labs in South San Francisco, we are a Series A-stage company with programs across rare and common diseases. The Role Addition Therapeutics is currently…
مقتطف من نص الإعلان الأصلي (الإنجليزية). التفاصيل الكاملة عند صاحب العمل.معرض وظائف لا يوظّف ولا يمثّل صاحب العمل. تفاصيل الإعلان الأصلي هي المرجع.